The most immediate threat to Edgewell's margin structure and market share is the accelerating competitive pressure in wet shaving from both ends of the market—Gillette's dominance at the premium end and Harry's/Dollar Shave Club's disruption at the value end—combined with a structurally declining category. Procter & Gamble's Gillette controls approximately 50% of the U.S. wet shave market, with substantially greater resources for advertising, R&D, and trade promotion. Gillette's 2023 launch of the GilletteLabs exfoliating razor and continued investment in the Venus women's franchise has maintained pressure on Edgewell's Schick and Wilkinson Sword brands. At the value end, Harry's—after its acquisition by Edgewell was blocked by the FTC in February 2020—has expanded into mass retail through Target and Walmart, achieving notable U.S. share gains since 2020 and compressing price ladders across the category. Dollar Shave Club, owned by Nexus Capital, maintains a subscription heritage with omnichannel presence that pressures replenishment models. The result is that Edgewell is squeezed between a dominant premium competitor and disruptive value competitors, with limited pricing power in a category where unit growth is slowing. The Wet Shave segment's FY2024 organic net sales declined 1.1% in Q4, with significant declines in shave preparations in North America, suggesting that the segment's growth is stalling even as profitability improves through cost reduction. Beyond competitive pressure, Edgewell faces significant regulatory and reputational risk in sun care. The July 2022 voluntary recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30 due to benzene contamination—followed by an expanded recall in January 2023 that added a fourth batch—created lasting consumer trust issues and regulatory scrutiny. Benzene, a known human carcinogen, was found in the propellant used in aerosol spray cans at concentrations that, while not expected to cause adverse health consequences according to independent health assessments, triggered FDA oversight and class-action litigation. The recalls affected Edgewell's FY2024 results through $4.4 million in sun care reformulation costs and contributed to the Sun and Skin Care segment's 4.4% decline in segment profit. The company has also faced Wet Ones manufacturing disruptions: a fire on December 1, 2023, at the Sidney, Ohio plant caused a partial shutdown of operations and incurred $12.2 million in incremental costs during FY2024. The Feminine Care segment's collapse—FY2024 net sales down 10.0% and segment profit down 42.1%—reflects structural decline in the tampon and pad categories as consumers shift to menstrual cups, period underwear, and organic alternatives. This segment's underperformance is the primary driver of the Essity divestiture. The company's manufacturing consolidation initiative, while necessary for long-term efficiency, carries near-term execution risk. The plan to consolidate four North American manufacturing sites into a single automated plant involves closing the Schick brand facility in Milford, Connecticut, by December 2027, eliminating 293 jobs. The company expects to incur pre-tax charges of approximately $29 million in FY2025 related to restructuring and repositioning actions. This consolidation, combined with the Feminine Care divestiture, will fundamentally reshape the company's cost structure and operational footprint. Perhaps the most underappreciated risk is the company's valuation trap: with a market cap of $935 million, total debt of approximately $1.9 billion (enterprise value of $1.9 billion), and a price-to-sales ratio of 0.41, Edgewell trades at a deep discount to peers. This low valuation limits the company's ability to use equity for acquisitions and increases the risk of activist intervention or a take-private transaction. The stock's one-year return of -25.06% as of March 2026 and three-year return of 49.19% reflect this volatility and uncertainty.